Literature DB >> 23856079

Steroids in Duchenne muscular dystrophy.

V Ricotti, D A Ridout, F Muntoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23856079     DOI： 10.1016/j.nmd.2013.06.373

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  4 in total

1.  Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.

Authors:  Luca Bello; Heather Gordish-Dressman; Lauren P Morgenroth; Erik K Henricson; Tina Duong; Eric P Hoffman; Avital Cnaan; Craig M McDonald
Journal:  Neurology       Date:  2015-08-26       Impact factor: 9.910

Review 2.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 3.  Nanotherapy for Duchenne muscular dystrophy.

Authors:  Michael E Nance; Chady H Hakim; N Nora Yang; Dongsheng Duan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-04-11

4.  Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy.

Authors:  Giorgia Coratti; Jacopo Lenkowicz; Giulia Norcia; Simona Lucibello; Elisabetta Ferraroli; Adele d'Amico; Luca Bello; Elena Pegoraro; Sonia Messina; Federica Ricci; Tiziana Mongini; Angela Berardinelli; Riccardo Masson; Stefano C Previtali; Grazia D'angelo; Francesca Magri; Giacomo P Comi; Luisa Politano; Luigia Passamano; Gianluca Vita; Valeria A Sansone; Emilio Albamonte; Chiara Panicucci; Claudio Bruno; Antonella Pini; Enrico Bertini; Stefano Patarnello; Marika Pane; Eugenio Mercuri
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.